Ally Bridge Group (Ny) LLC Nuvation Bio Inc. Transaction History

Ally Bridge Group (Ny) LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$4.6 - $8.83 $276,000 - $529,800	-60,000 Reduced 5.01%	1,137,152 $5.98 Million
Q4 2021 Feb 14, 2022	SELL	$7.75 - $10.05 $3.59 Million - $4.66 Million	-463,795 Reduced 27.92%	1,197,152 $10.2 Million
Q3 2021 Nov 15, 2021	SELL	$7.78 - $10.0 $366,780 - $471,440	-47,144 Reduced 2.76%	1,660,947 $16.5 Million
Q2 2021 Aug 16, 2021	SELL	$9.22 - $14.48 $2.69 Million - $4.23 Million	-291,909 Reduced 14.6%	1,708,091 $15.9 Million
Q1 2021 May 17, 2021	BUY	$9.0 - $14.57 $18 Million - $29.1 Million	2,000,000 New	2,000,000 $20.9 Million

158

157M

3.2K

98.7K

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $613M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.